Hong Kong, December 3, 2024: Pfizer has received authorization from health authorities for its 20-valent pneumococcal conjugate vaccine, aimed at infants and children. This vaccine is designed to protect against various strains of pneumococcal disease, which can lead to serious infections such as pneumonia and meningitis.
Hong Kong, November 28, 2024: ZEISS launched the MYO 200 Biometer for Myopia Management, a device specifically designed for children and adolescents. The MYO 200 enhances the accuracy of myopia assessments and integrates with ZEISS's software to support eye care professionals in monitoring and managing myopia effectively.
The prevalence of myopia among children in Hong Kong has become a significant public health concern, with over 40% of eight-year-olds affected, according to a study by the Chinese University of Hong Kong. The MYO 200 aims to address the urgent need for precise optical measurements in community settings, schools, and clinics.
ZEISS's MYO 200 features advanced technology that allows for quick and accurate assessments, facilitating timely interventions for children at risk of developing severe myopia. The device is designed to be user-friendly, enabling effective use in various environments beyond traditional hospitals.